...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Oral Supplementation With 25(OH)D_3 Versus Vitamin D_3: Effects on 25(OH)D Levels, Lower Extremity Function, Blood Pressure, and Markers of Innate Immunity
【24h】

Oral Supplementation With 25(OH)D_3 Versus Vitamin D_3: Effects on 25(OH)D Levels, Lower Extremity Function, Blood Pressure, and Markers of Innate Immunity

机译:口服补充25(OH)D_3与维生素D_3:对25(OH)D水平,下肢功能,血压和先天免疫标记的影响

获取原文
获取原文并翻译 | 示例
           

摘要

To test the effect of 25(OH)D_3 (HyD) compared to vitamin D_3 on serum 25-hydroxyvitamin D levels (25(OH)D), lower extremity function, blood pressure, and markers of innate immunity. Twenty healthy postmenopausal women with an average 25(OH)D level of 13.2+-3.9ng/mL (mean+-SD) and a mean age of 61.5 +-7.2 years were randomized to either 20 mug of HyD or 20mg (800IU) of vitamin D_3 per day in a double-blind manner. We measured on 14 visits over 4 months, 25(OH)D serum levels, blood pressure, and seven markers of innate immunity (eotaxin, interleukin [IL]-8, IL-12, interferon gamma-induced protein 10kDa [IP-10], monocyte chemotactic protein-1 [MCP-1], macrophage inflammatory protein beta [MIP-1beta], and "Regulated upon Activation, Normal T-cell Expressed, and Secreted" [RANTES]). At baseline and at 4 months, a test battery for lower extremity function (knee extensor and flexor strength, timed up and go, repeated sit-to-stand) was assessed. All analyses were adjusted for baseline measurement, age, and body mass index. Mean 25(OH)D levels increased to 69.5 ng/mL in the HyD group. This rise was immediate and sustained. Mean 25(OH)D levels increased to 31.0ng/mL with a slow increase in the vitamin D_3 group. Women on HyD compared with vitamin D_3 had a 2.8-fold increased odds of maintained or improved lower extremity function (odds ratio [OR] = 2.79; 95% confidence interval [Cl], 1.18-6.58), and a 5.7-mmHg decrease in systolic blood pressure (p = 0.0002). Both types of vitamin D contributed to a decrease in five out of seven markers of innate immunity, significantly more pronounced with HyD for eotaxin, IL-12, MCP-1, and MIP-1 p. There were no cases of hypercalcemia at any time point. Twenty micrograms (20 mug) of HyD per day resulted in a safe, immediate, and sustained increase in 25(OH)D serum levels in all participants, which may explain its significant benefit on lower extremity function, systolic blood pressure, and innate immune response compared with vitamin D_3.
机译:为了测试25(OH)D_3(HyD)与维生素D_3相比对血清25-羟基维生素D水平(25(OH)D),下肢功能,血压和先天性免疫指标的影响。二十名健康的绝经后妇女的平均25(OH)D水平为13.2 + -3.9ng / mL(平均值+ -SD),平均年龄为61.5 + -7.2岁,随机分为20杯HyD或20mg(800IU)每天以双盲方式服用维生素D_3。我们在4个月内的14次就诊,25(OH)D血清水平,血压和7种先天性免疫指标(eotaxin,白介素[IL] -8,IL-12,干扰素γ诱导的蛋白10kDa [IP-10] ],单核细胞趋化蛋白1 [MCP-1],巨噬细胞炎性蛋白β[MIP-1beta]和“激活后受调节,正常T细胞表达和分泌” [RANTES])。在基线和第4个月时,评估了下肢功能测试电池(膝盖伸肌和屈肌强度,定时走动,反复坐着站立)。调整所有分析的基线,年龄和体重指数。 HyD组的平均25(OH)D水平增加至69.5 ng / mL。这种上升是立即而持续的。随着维生素D_3组的缓慢增加,平均25(OH)D水平增加至31.0ng / mL。与维生素D_3相比,接受HyD治疗的女性下肢功能维持或改善的机率增加了2.8倍(优势比[OR] = 2.79; 95%置信区间[Cl],1.18-6.58),而维生素D_3降低了5.7mmHg收缩压(p = 0.0002)。两种类型的维生素D都会导致先天免疫的7种标记中的5种下降,其中以HyD显着增强嗜酸性粒细胞趋化因子,IL-12,MCP-1和MIP-1 p的表达。在任何时候都没有高钙血症的病例。每天20微克(20马克杯)的HyD导致所有参与者的25(OH)D血清水平安全,立即和持续增加,这可能解释了其对下肢功能,收缩压和先天免疫的显着益处与维生素D_3比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号